Could Moderna Be a Millionaire-Maker Stock?

Could Moderna Be a Millionaire-Maker Stock?

Moderna (NASDAQ: MRNA) is at a crucial moment right now -- for its COVID-19 vaccine candidate, its pipeline as a whole, and its investors. The company's investigational vaccine for COVID-19 is entering phase 3 clinical trials this month. Let's take a look at what Moderna has reported so far, as well as possible risks ahead.